Pharmacia Recalls Cleocin Phosphate Vials Due to Glass Delamination
Pharmacia & Upjohn LLC is recalling specific lots of Cleocin Phosphate injection vials due to the presence of very small reflective flakes consistent with glass delamination.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The rubric mandates a score of 4 for FDA Class II recalls, as the agency's own classification is Class II.
Plain-English summary
Pharmacia & Upjohn LLC is recalling a small number of vials of Cleocin Phosphate (clindamycin phosphate) Injection, USP. The recall involves 600 mg/4mL and 900 mg/6mL ADD-Vantage Vials intended for intravenous use only. The affected lots are G34908, G53479, G63442, G58347, G80133, G34910, G36879, G41005, G53478, G63444, and G76317, with expiration dates ranging from June 2014 to December 2014.
The recall was initiated because a small number of vials were found to contain very small reflective flakes. These flakes are consistent with delamination of the glass vial. The product was distributed nationwide.
Healthcare providers and patients should discontinue use of the affected lots and contact Pharmacia & Upjohn LLC for further instructions. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE)
- Brand
- CLEOCIN PHOSPHATE
- Manufacturer
- Pharmacia & Upjohn LLC
- Category
- Drug — Antibiotic Injection
- Affected units
- 898,900
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (17)
- Lots: a) G34908
- Exp 06/14
- G53479
- Exp 09/14
- G63442
- G58347
- Exp 10/14
- G80133
- Exp 12/14
- and b) G34910
- G36879
- G41005
- Exp 07/14
- G53478
- G63444
- G76317
- Exp 11/14.
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CLEOCIN PHOSPHATE
- LowPfizer Recalls Cleocin Phosphate Injection Due to Impurity Failures
FDA (Drugs) · 2019-04-10
- LowPfizer Recalls Cleocin Phosphate Injection Due to Impurity Failures
FDA (Drugs) · 2019-04-10
- ModeratePfizer Recalls Cleocin Phosphate Injection Due to Impurity Failures
FDA (Drugs) · 2019-04-10
Same hazard · glass delamination
See all →- HighVenofer Iron Sucrose Injection Recalled for Potential Glass Contamination
FDA (Drugs) · 2024-12-11
- HighPrescription Drug Recall: Venofer Iron Sucrose Vials with Glass Delamination Risk
FDA (Drugs) · 2024-12-11
- HighIron sucrose injection recall due to potential glass contamination in vials
FDA (Drugs) · 2024-12-11
- HighMoxifloxacin single-dose vials recalled for glass delamination nationwide
FDA (Drugs) · 2024-03-06
- SevereFresenius Kabi Recalls Tranexamic Acid Injection Due to Particulate Matter
FDA (Drugs) · 2014-01-29